Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 289
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02661035 | Allo HSCT Using RIC for Hematological Diseases | ||
| NCT00369291 | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant | ||
| NCT01158456 | Metabolism of NNK Among African Americans | ||
| NCT01215981 | Influenza Vaccine Post Allogeneic Transplant | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT03557749 | Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies | ||
| NCT05363267 | NF-1, Nutraceutical Intervention | ||
| NCT07153016 | LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer | ||
| NCT05447156 | QuitGuide for American Indians: Aims 2 & 3 | ||
| NCT05123040 | Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids | ||
| NCT00176891 | Stem Cell Transplant w/Laronidase for Hurler | ||
| NCT02162420 | Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia | ||
| NCT00871689 | Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML | ||
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | ||
| NCT00376519 | Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases | ||
| NCT00748163 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT04740008 | Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT03314974 | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders | ||
| NCT01639456 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission | ||
| NCT01451502 | Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units | ||
| NCT05705700 | Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) | ||
| NCT01105650 | Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer | ||
| NCT01043640 | Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders | ||
| NCT01173016 | Administration of IV Laronidase Post Bone Marrow Transplant in Hurler | ||
| NCT06772090 | Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies | ||
| NCT01593618 | Empowering Cancer Survivors Through Information Technology | ||
| NCT00352976 | TBI Dose De-escalation for Fanconi Anemia | ||
| NCT00177047 | Autologous Transplant for Multiple Myeloma | ||
| NCT01526603 | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | ||
| NCT00610740 | CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer | ||
| NCT02765997 | StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies | ||
| NCT00258427 | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia | ||
| NCT03687073 | Trial of Indole-3-Carbinol and Silibinin | ||
| NCT05809557 | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | ||
| NCT04228952 | Metabolism of NNK in Japanese Americans | ||
| NCT03981705 | Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer | ||
| NCT02395822 | MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients | ||
| NCT02410239 | MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) | ||
| NCT01056601 | Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy | ||
| NCT02582775 | MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs | ||
| NCT04630769 | FT516 and IL2 With Enoblituzumab for Ovarian Cancer | ||
| NCT04882423 | Vegetable Intake Effect on Heterocyclic Amine Metabolism | ||
| NCT00287859 | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT02370160 | HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma | ||
| NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | ||
| NCT00818649 | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT00383448 | HSCT for High Risk Inherited Inborn Errors | ||
| NCT00618540 | Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis | ||
| NCT00167219 | Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) |
